-
The Regents of the University of California$2,070,000 through November, 2018
to support the UCLA MS Research & Treatment Program's ongoing work of establishing a disability specific pipeline to develop generic, inexpensive neuroprotective drugs to halt progression of specific disabilities related to Multiple Sclerosis.
-
New York Stem Cell Foundation, Inc.$200,000 through December, 2016
to support research towards treatments and a cure for multiple sclerosis.
-
Washington University$900,000 through December, 2019
to utilize the gradient echo plural contract imaging technique to detect and measure evolution of progressive MS.
-
Oregon Health and Science University$900,000 through December, 2019
to utilize magnetic resonance imaging techniques to map human brain metabolic activity in Multiple Sclerosis and determine if metabolic deficits predict brain tissue loss.
-
Winthrop University Hospital Association$440,000 through June, 2017
to develop a minimally invasive DNA-based biomarker assay for the detection of cell loss in autoimmune diseases.
-
Johns Hopkins University$900,000 through June, 2019
to identify lipid biomarkers of progressive MS.
-
J. David Gladstone Institutes$495,000 through June, 2017
to explore the potential of the coagulation cascade as a unique niche for biomarkers in progressive Multiple Sclerosis.
-
Salk Institute for Biological Studies$900,000 through December, 2017
to develop in vitro models to study subtypes of MS using human cells.
-
National Multiple Sclerosis Society, Southern California & Nevada Chapter$1,100,000 through December, 2022
for the Fast Forward Fund, which funds pharmaceutical and biotechnology companies developing innovative therapeutics and diagnostic strategies for Multiple Sclerosis.
-
National Multiple Sclerosis Society, Southern California & Nevada Chapter$1,000,000 through September, 2018
to fund a cost-benefit analysis of current Multiple Sclerosis Adult Day Programs.
Our grantmaking in 2023
$289,999,832 paid in 2023Click on the diagram sections for information specific to each of our program areas listed below.
View grantmaking in 2022This amount represents grantmaking within our Catholic Sisters program
About ProgramThis amount represents grantmaking within our Disaster Relief & Recovery program
About ProgramThis amount represents grantmaking within our Global Early Childhood Development program
About ProgramThis amount represents grantmaking within our US-focused Early Childhood Development program
About ProgramThis amount represents general operating support grants awarded to organizations led by under-represented populations
This amount represents grantmaking within our Foster Youth program
About ProgramThis amount represents grantmaking within our Homelessness program
About ProgramThis amount represents grantmaking within our Opportunity Youth program
About ProgramThis amount represents total giving towards non-priority grantmaking which includes small and matching discretionary grant programs for board members, staff and members of the Hilton family.
This amount represents grantmaking within our Partnerships portfolio
About our partnersThis amount represents total giving towards Program-Related Investments
This amount represents grantmaking within our Refugees program
About ProgramThis amount represents grantmaking within our Safe Water program
About Program- Catholic Sisters
- Disaster Relief & Recovery
- Early Childhood Development: East and Southern Africa
- Early Childhood Development: United States
- Equity Fund
- Foster Youth
- Homelessness
- Opportunity Youth
- Other
- Partnerships
- Program-Related Investments
- Refugees
- Safe Water
This total represents approved grant payment activity during the selected fiscal year. However, approximately 90% of the money awarded in our program areas is part of multi-year commitments, so a grant may appear in multiple years of activity. The list below provides additional information about specific projects approved and/or paid during the fiscal year selected, including the project start date and the length of our commitment.